Pulmonary Medicine

Lung Cancer Screening


Low-dose CT (LDCT) lung cancer screening detects lung cancer early in high-risk adults. Early detection significantly improves survival rates, especially at Stage I, versus late-stage diagnosis.

Overview

About Lung Cancer Screening

Low-dose CT (LDCT) lung cancer screening detects lung cancer early in high-risk adults. Early detection significantly improves survival rates, especially at Stage I, versus late-stage diagnosis.


If you are between the ages 50 and 80 and have been smoking tobacco at least one pack a day for at least 20 years, BOOK an appointment today to be checked for lung cancer and COPD.

Lung cancer screening using low-dose computed tomography (LDCT) is an essential tool for early detection of lung cancer in high-risk individuals. Here's what you need to know:

Indication and Eligibility

Lung cancer screening is recommended for adults who meet the following criteria:

  • Age: 50 to 80 years old
  • Smoking history: At least a 20 pack-year history (equivalent to smoking 1 pack per day for 20 years or two packs per day for 10 years)
  • Current smokers or those who have quit within the past 15 years.

Screening Effectiveness

  • Number needed to screen: Approximately 320 high-risk individuals must be screened over five years to prevent one lung cancer death.
  • Early detection benefit: When lung cancer is detected at an early stage, the five-year survival rate can be as high as 59%, compared to only 6% for late-stage diagnosis.

False Positive Rate

The false positive rate for lung cancer screening varies:

  • Initial screening: About 12-14% of initial screenings may result in a false positive.
  • Subsequent annual screenings: The false positive rate drops to 6% for continued annual screening scans.
  • It's important to note that most positive results are false positives. 95% of abnormal LDCT results are false positives.

Impact on Survival Rate

Lung cancer screening has shown significant improvements in long-term survival:

  • 20-year survival rate: Patients diagnosed with lung cancer through LDCT screening have a 20-year survival rate of 81%.
  • Stage I survival: For those diagnosed with stage I lung cancer through screening, the 20-year survival rate increases to 87%.
  • Early-stage detection: 81% of lung cancers detected through screening are found at stage I, when treatment is most effective.

Back to Pulmonary Medicine

Lung Cancer Screening
Patient Reviews

What our patients say

Recent Google reviews from patients of Auria Medical Clinics.

Deborah Hurley

a year ago

This practice has treated me and my husband for about 11 years. Seen me through some very traumatic medical conditions and been the most nurturing professional and caring primary Doctor I’ve had in my lifetime. I consider Dr Zafar an above and beyond kind of person and practitioner. And I absolutely adore her front desk folks!! The absolute best. You will never feel unheard or cared for here.

Madiha

11 months ago

I’ve been coming to Dr. Zafar for almost 10 years now. She has been there for me through so much. Kind and Compassionate doesn’t begin to cover it. And her team is really kind and caring too. Dr. Zafar does excellent with patient education and answers any and all questions, very easy to talk to. She is your biggest cheerleader when it comes to your health!

Nicole G.

6 months ago

Not one complaint. Office staff was very friendly and warming. Dr. Araghi was great to talk to and visit was quick, no long time to wait. Would definitely recommend.

Ready to visit

Schedule with our Suwanee team

Our team of pulmonologists combines years of experience with cutting-edge treatments to provide the best outcomes for your respiratory health.